SEMA4D and Alzheimer disease: An initial mutant huntingtin‐dependent (or, in AD, Aβ amyloid or Tau‐dependent) phase that damages neurons and leads to upregulation of SEMA4D followed by a SEMA4D‐dependent neuroinflammatory phase that significantly amplifies and aggravates damage.